Tudor Investment Corp ET AL Sells 105,267 Shares of Enhabit, Inc. (NYSE:EHAB)

Tudor Investment Corp ET AL lowered its position in Enhabit, Inc. (NYSE:EHAB - Free Report) by 60.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 70,064 shares of the company's stock after selling 105,267 shares during the period. Tudor Investment Corp ET AL owned about 0.14% of Enhabit worth $547,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. JPMorgan Chase & Co. boosted its position in shares of Enhabit by 37.8% in the third quarter. JPMorgan Chase & Co. now owns 305,245 shares of the company's stock valued at $2,411,000 after acquiring an additional 83,707 shares during the period. Paradice Investment Management LLC grew its holdings in Enhabit by 12.8% in the 4th quarter. Paradice Investment Management LLC now owns 1,780,113 shares of the company's stock worth $13,903,000 after acquiring an additional 201,997 shares during the last quarter. Corient Private Wealth LLC bought a new position in Enhabit during the 4th quarter valued at approximately $79,000. Rhumbline Advisers increased its stake in shares of Enhabit by 2.8% during the fourth quarter. Rhumbline Advisers now owns 80,760 shares of the company's stock valued at $631,000 after buying an additional 2,211 shares during the period. Finally, Empowered Funds LLC increased its position in Enhabit by 5.0% during the 4th quarter. Empowered Funds LLC now owns 175,824 shares of the company's stock valued at $1,373,000 after purchasing an additional 8,448 shares during the period.

Enhabit Stock Performance

EHAB traded down $0.02 during midday trading on Wednesday, hitting $10.46. 141,961 shares of the company traded hands, compared to its average volume of 466,075. The company has a quick ratio of 1.46, a current ratio of 1.46 and a debt-to-equity ratio of 0.85. The firm has a market capitalization of $529.41 million, a PE ratio of -4.51 and a beta of 1.61. The company's 50-day moving average is $8.41 and its 200 day moving average is $8.13. Enhabit, Inc. has a 52 week low of $6.85 and a 52 week high of $10.70.

Enhabit (NYSE:EHAB - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of $0.07 by $0.03. Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. The firm had revenue of $259.90 million for the quarter, compared to analysts' expectations of $266.11 million. On average, research analysts expect that Enhabit, Inc. will post 0.22 EPS for the current year.

Analysts Set New Price Targets

Separately, Jefferies Financial Group reissued a "buy" rating on shares of Enhabit in a research report on Thursday, March 6th.

Enhabit Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.